NYSEMKT: SENSSenseonics Holdings Inc Stock
$0.43+0.00 (+0%)
Updated Apr 24, 2024
SENS Price
$0.43
Fair Value Price
N/A
Market Cap
$229.78M
52 Week Low
$0.38
52 Week High
$1.05
P/E
-3.94x
P/B
6.42x
P/S
14.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$22.39M
Earnings
-$60.39M
Gross Margin
13.8%
Operating Margin
-220.11%
Profit Margin
-269.7%
Debt to Equity
1.81
Operating Cash Flow
-$70M
Beta
1.5
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
SENS Overview
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SENS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SENS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SENS is poor value based on its book value relative to its share price (6.42x), compared to the US Medical Devices industry average (3.73x)
P/B vs Industry Valuation
SENS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SENS due diligence checks available for Premium users.
Be the first to know about important SENS news, forecast changes, insider trades & much more!
SENS News
Valuation
SENS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.94x
Industry
30.46x
Market
41.27x
SENS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.42x
Industry
3.73x
SENS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SENS's financial health
Profit margin
Revenue
$8.0M
Net Income
-$17.2M
Profit Margin
-214.1%
SENS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SENS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$138.2M
Liabilities
$64.8M
Debt to equity
1.81
SENS's short-term assets ($130.03M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SENS's short-term assets ($130.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SENS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SENS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$15.1M
Investing
$36.2M
Financing
-$1.2M
SENS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SENS vs Medical Device Stocks
Senseonics Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.